CIK 0000718937
- Large accelerated filer
STAAR SURGICAL CO
Sign in to watch- Ticker
- STAA
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Jan 2
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953797439
- Phone
- +1 626-303-7902
- Business address
- 1911 WALKER AVE, MONROVIA, CA, 91016
- Former names
- STAAR SURGICAL COMPANY
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-14 | Holliday Keith Chief Technology Officer | Exercise or conversion · Common Stock Options | −3,994 | 21,006 | ||
| 2020-09-09 | Moore John C Director | Sale | −137,331 | $52.04 | $7.1M | 21,387 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +16,206 | $9.30 | $151K | 27,000 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +5,822 | $7.52 | $44K | 32,822 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +11,574 | $8.64 | $100K | 44,396 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion | +8,000 | $16.15 | $129K | 52,396 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Sale | −41,602 | $51.22 | $2.1M | 10,794 |
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −16,206 | 0 | ||
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −5,822 | 0 | ||
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −11,574 | 0 | ||
| 2020-08-10 | Hayashida Jon K. VP, Global Clinical, Medical | Exercise or conversion · Common Stock Options | −8,000 | 6,476 | ||
| 2020-08-10 | Williams Patrick F. Chief Financial Officer | Grant or award | +30,727 | 30,727 | ||
| 2020-07-30 | SILVERMAN LOU Director | Grant or award | +2,117 | 15,850 | ||
| 2020-07-30 | FARRELL STEPHEN C Director | Grant or award | +2,117 | 5,808 | ||
| 2020-07-30 | Moore John C Director | Grant or award | +2,117 | 2,117 | ||
| 2020-07-30 | Kliman Gilbert H Director | Grant or award | +2,117 | 2,581 | ||
| 2020-07-30 | FRINZI THOMAS G Director | Grant or award | +2,117 | 2,117 | ||
| 2020-07-01 | BROADWOOD PARTNERS, L.P. 10% owner | Other disposition | −4,062 | 10,795,348 | ||
| 2020-07-01 | BROADWOOD PARTNERS, L.P. 10% owner | Other disposition | −0 | 10,795,348 | ||
| 2020-06-15 | Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China | Exercise or conversion | +19,215 | $11.00 | $211K | 147,165 |
Page 41 of 50 · 987 trades